P3.13C.06 Artificial Intelligence Meets SCLC - Integrating Clinicopathological and Whole-Slide Image Data for Prognostic Prediction in SCLC.

Autor: Rocha, P., Gibert, J., Menendez, S., del Rey-Vergara, R., Iñañez, A., Masfarre, L., Navarro, N., Rios-Hoyo, A., Perez, S., Taus, Á., Giner, M., Rovira, A., León-Mateos, L., Isla, D., Paz-Ares, L., Zugazagoitia, J., Martí Blanco, C., García-Campelo, R., Moreno-Vega, A., Callejo, A.

Publikováno v: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS356-S357, 2p

P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade

Autor: Rocha, P., Bach, R., Masfarre, L., Hernandez, S., Navarro-Gorro, N., Rossell, A., Villanueva, X., Giner, M., Sanchez, I., Galindo, M., del Rey-Vergara, R., Iñañez, A., Sanchéz-Espiridion, B., Lu, W., Acedo-Terrades, A., Berenguer-Molins, P., Sánchez-Font, A., Chalela, R., Curull, V., Taus, Á., Hardy-Werbin, M., Sausen, M., Georgiadis, A., White, J., Jackson, J.B., Moliner, L., Clavé, S., Bellosillo, B., Rovira, A., Wistuba, I., Solis Soto, L.M., Perera-Bel, J., Arriola, E.

Publikováno v: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S255-S255

Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.

Autor: Rocha P; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Rodrigo M; Pathology Department, Hospital del Mar, Barcelona, Spain., Moliner L; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain; Medical Oncology Department, Catalan Institute of Oncology (ICO), Barcelona, Spain., Menendez S; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Masfarré L; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain., Navarro N; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain., Del Rey-Vergara R; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Galindo-Campos M; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Taus Á; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Giner M; Pathology Department, Hospital del Mar, Barcelona, Spain., Sanchez I; Pathology Department, Hospital del Mar, Barcelona, Spain., Rodríguez-Fuster A; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain; Thoracic Surgery Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain., Aguiló R; Thoracic Surgery Department, Hospital del Mar, Barcelona, Spain., Chalela R; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain; Pulmonology Department, Hospital del Mar, Barcelona, Spain., Sánchez-Font A; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Pulmonology Department, Hospital del Mar, Barcelona, Spain., Belda J; Thoracic Surgery Department, Hospital del Mar, Barcelona, Spain., Curull V; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain; Thoracic Surgery Department, Hospital del Mar, Barcelona, Spain; Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain., Pijuan L; Pathology Department, Hospital del Mar, Barcelona, Spain., Casadevall D; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Clavé S; Pathology Department, Hospital del Mar, Barcelona, Spain., Bellosillo B; Pathology Department, Hospital del Mar, Barcelona, Spain., Perera-Bel J; Pulmonology Department, Hospital del Mar, Barcelona, Spain., Comerma L; Pathology Department, Hospital del Mar, Barcelona, Spain., Arriola E; Medical Oncology Department, Hospital del Mar - CIBERONC, Barcelona, Spain; IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain. Electronic address: earriola@psmar.cat.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jul; Vol. 181, pp. 107257. Date of Electronic Publication: 2023 May 20.

1386P Validation of MET amplification using next-generation sequencing in lung adenocarcinoma

Autor: Salido, M., Clavé, S., Sánchez, I., Rocha, P., Masfarre Pinto, L., Navarro Gorro, N., Galindo Campos, M.A., Del Rey-Vergara, R., Taus Garcia, A., Espinet, B., Arriola, E., Bellosillo Paricio, B.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S795-S795

49P Identifying peripheral immune predictors of durable clinical response to PD-L1 blockade in small cell lung cancer

Autor: Galindo Campos, M.A., Hardy-Werbin, M., Rios Hoyo, A., Gibert, J., Rossell, A., Gonzalez, S., Simoes da Rocha, P.F., Del Rey-Vergara, R., Masfarré, L., Navarro Gorro, N., Taus Garcia, A., Rovira, A., Arriola, E.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S561-S562